These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21924537)

  • 1. Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia.
    Mazhari S; Price G; Dragović M; Waters FA; Clissa P; Jablensky A
    Brain Cogn; 2011 Nov; 77(2):223-30. PubMed ID: 21924537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisaccade performance is related to genetic loading for schizophrenia.
    Petrovsky N; Weiss-Motz F; Schulze-Rauschenbach S; Lemke M; Hornung P; Ruhrmann S; Klosterkötter J; Maier W; Ettinger U; Wagner M
    J Psychiatr Res; 2009 Jan; 43(3):291-7. PubMed ID: 18585739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does performance on the standard antisaccade task meet the co-familiality criterion for an endophenotype?
    Levy DL; Bowman EA; Abel L; Krastoshevsky O; Krause V; Mendell NR
    Brain Cogn; 2008 Dec; 68(3):462-75. PubMed ID: 18842329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives.
    Curtis CE; Calkins ME; Grove WM; Feil KJ; Iacono WG
    Am J Psychiatry; 2001 Jan; 158(1):100-6. PubMed ID: 11136640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intact emotion-cognition interaction in schizophrenia patients and first-degree relatives: evidence from an emotional antisaccade task.
    Aichert DS; Derntl B; Wöstmann NM; Groß JK; Dehning S; Cerovecki A; Möller HJ; Habel U; Riedel M; Ettinger U
    Brain Cogn; 2013 Aug; 82(3):329-36. PubMed ID: 23807237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.
    Calkins ME; Iacono WG; Ones DS
    Brain Cogn; 2008 Dec; 68(3):436-61. PubMed ID: 18930572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia-related RGS4 gene variations specifically disrupt prefrontal control of saccadic eye movements.
    Kattoulas E; Stefanis NC; Avramopoulos D; Stefanis CN; Evdokimidis I; Smyrnis N
    Psychol Med; 2012 Apr; 42(4):757-67. PubMed ID: 21910931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye tracking in schizophrenia: does the antisaccade task measure anything that the smooth pursuit task does not?
    Zanelli J; Simon H; Rabe-Hesketh S; Walshe M; McDonald C; Murray RM; Maccabe JH
    Psychiatry Res; 2005 Sep; 136(2-3):181-8. PubMed ID: 16111769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological brain activity and antisaccade performance in schizophrenia patients with first-rank (passivity) symptoms.
    Waters F; Price G; Dragović M; Jablensky A
    Psychiatry Res; 2009 Dec; 170(2-3):140-9. PubMed ID: 19906434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between prepulse inhibition and antisaccadic deficits in chronic schizophrenia: implications for identification of schizophrenia endophenotypes.
    Kumari V; Ettinger U; Crawford TJ; Zachariah E; Sharma T
    J Psychiatr Res; 2005 May; 39(3):227-40. PubMed ID: 15725421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccadic system functioning among schizophrenia patients and their first-degree biological relatives.
    Clementz BA; McDowell JE; Zisook S
    J Abnorm Psychol; 1994 May; 103(2):277-87. PubMed ID: 8040497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories.
    Reilly JL; Frankovich K; Hill S; Gershon ES; Keefe RS; Keshavan MS; Pearlson GD; Tamminga CA; Sweeney JA
    Schizophr Bull; 2014 Sep; 40(5):1011-21. PubMed ID: 24080895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisaccade deficit is present in young first-episode patients with schizophrenia but not in their healthy young siblings.
    de Wilde OM; Bour L; Dingemans P; Boerée T; Linszen D
    Psychol Med; 2008 Jun; 38(6):871-5. PubMed ID: 17949519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study.
    Ettinger U; Picchioni M; Hall MH; Schulze K; Toulopoulou T; Landau S; Crawford TJ; Murray RM
    Am J Psychiatry; 2006 Mar; 163(3):543-5. PubMed ID: 16513882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Reuter B; Rakusan L; Kathmanna N
    Psychiatry Res; 2005 May; 135(1):1-10. PubMed ID: 15893384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fixation condition manipulations on antisaccade performance in schizophrenia: studies of diagnostic specificity.
    McDowell JE; Clementz BA
    Exp Brain Res; 1997 Jun; 115(2):333-44. PubMed ID: 9224861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies.
    Radant AD; Millard SP; Braff DL; Calkins ME; Dobie DJ; Freedman R; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Meichle SP; Nuechterlein KH; Olincy A; Seidman LJ; Siever LJ; Silverman JM; Stone WS; Swerdlow NR; Sugar CA; Tsuang MT; Turetsky BI; Tsuang DW
    Schizophr Res; 2015 Apr; 163(1-3):47-52. PubMed ID: 25553977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saccadic distractibility is elevated in schizophrenia patients, but not in their unaffected relatives.
    Maccabe JH; Simon H; Zanelli JW; Walwyn R; McDonald CD; Murray RM
    Psychol Med; 2005 Dec; 35(12):1727-36. PubMed ID: 16300688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful multi-site measurement of antisaccade performance deficits in schizophrenia.
    Radant AD; Dobie DJ; Calkins ME; Olincy A; Braff DL; Cadenhead KS; Freedman R; Green MF; Greenwood TA; Gur RE; Light GA; Meichle SP; Mintz J; Nuechterlein KH; Schork NJ; Seidman LJ; Siever LJ; Silverman JM; Stone WS; Swerdlow NR; Tsuang MT; Turetsky BI; Tsuang DW
    Schizophr Res; 2007 Jan; 89(1-3):320-9. PubMed ID: 17023145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concordance study of three electrophysiological measures in schizophrenia.
    Louchart-de la Chapelle S; Nkam I; Houy E; Belmont A; Ménard JF; Roussignol AC; Siwek O; Mezerai M; Guillermou M; Fouldrin G; Levillain D; Dollfus S; Campion D; Thibaut F
    Am J Psychiatry; 2005 Mar; 162(3):466-74. PubMed ID: 15741463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.